Barclays maintains Blue Owl Capital at Equal-Weight, raises price target to $11 from $10

Barclays kept Blue Owl Capital at Equal-Weight, raising its price target to $11 from $10, a 10% increase. This implies a 5.7% upside from the Oct 29 close of $10.41. Recent analyst targets for the company range from $10 to $16.

Original reporting
Published Oct 30, 2026, 1:54 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 30, 2026, 1:57 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Barclays maintains Blue Owl Capital at Equal-Weight, raises price target to $11 from $10 — source image
Decision brief

The 30-second read

$OWLNeutralLow
01

Why it matters

The upgrade could attract short‑term interest but lacks a catalyst beyond the analyst note.

02

Market read

A modest analyst upgrade with limited immediate market impact.

03

What to watch

No new fundamental data; the upgrade is based on analyst opinion alone.

Relevance 5/10Novelty 4/10Timing: today

Background

Barclays maintains an Equal‑Weight rating on Blue Owl Capital and updates its price target.

Company-level read

Ticker impact

$OWLNeutralMedium confidence
Context

Barclays raised its price target on Blue Owl Capital to $11 from $10, indicating a fresh analyst upgrade.

Expected impact

potential modest upside as the market prices in the higher target

Evidence & confidence

Analyst target increase is new information but limited in scale; likely to generate modest buying pressure.

Market effects

Minimal impact on the broader asset management sector.

Limited to US equity markets where the stock trades.

Low; the news is company‑specific.

Counterpoint

Target raise may be overly optimistic if broader market sentiment stays weak.

Key entities

  • Barclays

    Equity research firm issuing the target raise.

  • Blue Owl Capital

    Asset management firm (ticker OWL).

Related articles

$OWLMed

Raymond James lowers Blue Owl Capital stock price target on slower wealth channel recovery

Raymond James cut its price target for Blue Owl Capital (NYSE: OWL) to $15 from $20, citing slower-than-expected recovery in wealth channel credit products. The firm adjusted EPS estimates, noting the stock trades at 11x next 12-month consensus EPS. Blue Owl reported Q3 2026 earnings of $0.24 per share, beating estimates, with revenue of $806.53 million and 12% AUM growth. Piper Sandler and Evercore ISI also raised their price targets.

$OWLMed

Piper Sandler raises Blue Owl Capital stock price target on results

Piper Sandler raised its price target for Blue Owl Capital (NYSE: OWL) to $13.00 from $12.00, citing strong results and increased earnings estimates. The company reported record fundraising, exceeding 2026 earnings forecasts, and shares rose 7%. Blue Owl's Q3 2026 earnings beat estimates, with a 15.54% revenue surprise and a 12% increase in assets under management to $330 billion.

$OWLMedAI 8/10

Blue Owl Capital Q3 Earnings Call Highlights

Blue Owl Capital reported $36B of AUM not yet earning fees, expected to generate $400M in annual fees. Credit fundraising totaled $5.6B, with real assets up 37%. Gross returns ranged from 6.4% to 13.4% across sectors. The company expects 2026 fee-related earnings to exceed $1.02 per share and anticipates margin expansion in 2027.

$OWLMed

Evercore ISI raises Blue Owl Capital stock price target on growth

Evercore ISI raised Blue Owl Capital's (NYSE:OWL) price target to $12.00 from $11.00, citing growth in direct lending and fee-paying assets. The stock trades at $10.41, with analysts seeing 22% upside. Blue Owl reported Q3 2026 earnings of $0.24 per share on $806.53M revenue, beating estimates, and increased AUM to $330B. The company maintains an 8.84% dividend yield and expects earnings growth in 2027.